Sophia Genetics is a precision medicine company that develops and commercializes SOPHiA DDM, a cloud-based software platform that uses artificial intelligence and machine learning to analyze genomic and multimodal clinical data for diagnostic and research purposes. The company serves hospitals, clinical laboratories, academic institutions, and biopharmaceutical companies across multiple regions, generating revenue through SaaS subscriptions, product sales of diagnostic kits and reagents, computational analysis services, and collaborative partnerships. The platform integrates next-generation sequencing analysis, genomic interpretation, and clinical decision support tools to help healthcare providers and researchers make informed diagnostic and treatment decisions, though the company continues to pursue regulatory clearances in major markets like the United States while maintaining approvals in other jurisdictions.